These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 686343
1. Hexafluorenium in renal failure. Kleine JW, Moesker A. Anaesthesia; 1978; 33(7):649-50. PubMed ID: 686343 [No Abstract] [Full Text] [Related]
2. [THE COMBINATION OF HEXAFLUORENIUM, SUCCINYLCHOLINE AND FLUOTHANE IN ANESTHESIA. PRELIMINARY NOTE]. RIZZI R, GIUSSANI A. Acta Anaesthesiol; 1964; 15():53-62. PubMed ID: 14131757 [No Abstract] [Full Text] [Related]
3. Prevention of suxamethonium-induced changes in serum potassium concentration by hexafluorenium. Is their combined use justified? Radnay PA, Badola RP, Dalsania A, El-Gaweet EI, Duncalf D. Br J Anaesth; 1979 May; 51(5):447-51. PubMed ID: 444345 [Abstract] [Full Text] [Related]
4. Prevention of succinylcholine induced hyperkalemia by neurolept anesthesia and hexafluorenium in anephric patients. Radnay PA, El-Gaweet ES, Novakovic M, Badola R, Cizmar S, Duncalf D. Anaesthesist; 1981 Jul; 30(7):334-7. PubMed ID: 6455928 [Abstract] [Full Text] [Related]
5. Potentiation of the neuromuscular effect of succinylcholine by hexafluorenium. FOLDES FF, HILLMER NR, MOLLOY RE, MONTE AP. Anesthesiology; 1960 Jul; 21():50-8. PubMed ID: 13823695 [No Abstract] [Full Text] [Related]
6. Hexafluorenium bromide: current status and a review. Britton RM, Figueroa M. Anesth Analg; 1973 Jul; 52(1):100-5. PubMed ID: 4567515 [No Abstract] [Full Text] [Related]
7. [HEXAFLUORENIUM, POTENTIATOR OF SUCCINYLCHOLINE]. JOBIDON A, PARADIS B, LABRECQUE A, DOUVILLE G. Can Anaesth Soc J; 1964 Jan; 11():88-100. PubMed ID: 14099695 [No Abstract] [Full Text] [Related]
11. THE BLOCKING ACTION OF HEXAFLUORENIUM ON NEUROMUSCULAR TRANSMISSION AND ITS INTERACTION WITH SUCCINYLCHOLINE. NASTUK WL, KARIS JH. J Pharmacol Exp Ther; 1964 May; 144():236-52. PubMed ID: 14183436 [No Abstract] [Full Text] [Related]
12. THE EFFECTS OF HEXAFLUORENIUM AND EDROPHONIUM ON THE NEUROMUSCULAR BLOCKING ACTIONS OF SUCCINYLCHOLINE, DECAMETHONIUM, IMBRETIL AND D-TUBOCURARINE. KATZ RL, GISSEN AJ, KARIS JH. Anesthesiology; 1965 May; 26():154-61. PubMed ID: 14261050 [No Abstract] [Full Text] [Related]
13. The interactions of hexafluorenium with depolarizing and competitive neuromuscular blocking agents. Scaf AH, van den Akker J, Berends F. Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):166-76. PubMed ID: 4276930 [No Abstract] [Full Text] [Related]
14. [Clinial experience using hexafluorenium]. Díaz Moreno A, Avello García F. Rev Esp Anestesiol Reanim; 1970 Jan; 17(1):165-9. PubMed ID: 4244445 [No Abstract] [Full Text] [Related]
15. [Hexafluorenium, antagonist of hexabiscarbacholine during anesthesia in humans]. MOSTERT JW. Can Anaesth Soc J; 1963 May; 10():241-3. PubMed ID: 13936235 [No Abstract] [Full Text] [Related]
16. [The use of hexafluorenium (mylaxen) in anesthesia]. Hudon R, Prud'homme G. Union Med Can; 1967 Mar; 96(3):290-4. PubMed ID: 5615018 [No Abstract] [Full Text] [Related]
17. [CHOLINESTERASE INHIBITORS IN ANESTHESIA, WITH SPECIAL REFERENCE TO HEXAFLUORENIUM (MYLAXEN)]. VAN HEMERTV. Ned Tijdschr Geneeskd; 1964 Oct 03; 108():1931-2. PubMed ID: 14242486 [No Abstract] [Full Text] [Related]
18. Synergistic effect of acidosis and succinylcholine-induced hyperkalemia in spinal cord transected rats. Koller ME, Breivik H, Greider P, Jones DJ, Smith RB. Acta Anaesthesiol Scand; 1984 Feb 03; 28(1):87-90. PubMed ID: 6711267 [Abstract] [Full Text] [Related]
19. Hexafluorenium-suxamethonium interaction in patients with normal versus atypical cholinesterase. Baraka A. Br J Anaesth; 1975 Aug 03; 47(8):885-8. PubMed ID: 1201167 [Abstract] [Full Text] [Related]
20. [Neuromuscular effects of hexafluorene bromide in association with succinylcholine]. Rodríguez Alvarez E. Rev Esp Anestesiol Reanim; 1978 Sep 03; 25(5):426-44. PubMed ID: 155278 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]